BXP.L

Beximco Pharmaceuticals Limited [BXP.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BXP.L Stock Summary

Top 10 Correlated ETFs

BXP.L


Top 10 Correlated Stocks

BXP.L


In the News

BXP.L Financial details

Company Rating
Buy
Market Cap
477.88M
Income
4.48B
Revenue
37.97B
Book val./share
95.65
Cash/share
2.21
Dividend
3.32
Dividend %
0.06%
Employees
5.5K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
511.57
Forward P/E
-
PEG
-402.6
P/S
1.71
P/B
53.67
P/C
17.19
P/FCF
-21.83
Quick Ratio
0.07
Current Ratio
1.58
Debt / Equity
0.52
LT Debt / Equity
0.07
-
-
EPS (TTM)
10.03
EPS next Y
-
EPS next Q
-
EPS this Y
-0.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
15.1%
Revenue last 5Y
14.37%
Revenue Q/Q
-3.41%
EPS Q/Q
-23.1%
-
-
-
-
SMA20
-2.5%
SMA50
-4.88%
SMA100
-22%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
11%
ROC
0.12%
Gross Margin
44%
Oper. Margin
18%
Profit Margin
12%
Payout
35%
Shs Outstand
1.27B
Shs Float
297.32M
-
-
-
-
Target Price
-
52W Range
0.0-85.0
52W High
-
52W Low
-
RSI
35
Rel Volume
13.24
Avg Volume
20.78K
Volume
275K
Perf Week
-2.56%
Perf Month
-9.52%
Perf Quarter
-32.74%
Perf Half Y
-26.21%
-
-
-
-
Beta
0.743188
-
-
Volatility
0.49%, 1.74%
Prev Close
0%
Price
38
Change
-

BXP.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-06-30

Metric History 2018-06-302019-06-302020-06-302021-06-30 2022-06-30
Revenue per share
39.6951.1557.4466.1177.71
Net income per share
5.686.87.8811.4911.48
Operating cash flow per share
4.070000
Free cash flow per share
-7.26-10.19-5.1-5.73-6.59
Cash per share
1.642.091.421.512.62
Book value per share
60.6666.3272.8783.0191.01
Tangible book value per share
57.1762.7369.4679.4488.32
Share holders equity per share
60.6666.3272.8783.0191.01
Interest debt per share
26.2632.5425.8319.0329.98
Market cap
22.45B16.23B14.88B44.06B34.79B
Enterprise value
33.24B29.1B24.75B51.02B45.99B
P/E ratio
8.855.354.238.596.79
Price to sales ratio
1.270.710.581.491
POCF ratio
12.340000
PFCF ratio
-6.93-3.57-6.54-17.22-11.83
P/B Ratio
0.830.550.461.190.86
PTB ratio
0.830.550.461.190.86
EV to sales
1.881.280.971.731.33
Enterprise value over EBITDA
75.854.377.055.98
EV to operating cash flow
18.270000
EV to free cash flow
-10.26-6.4-10.88-19.94-15.64
Earnings yield
0.110.190.240.120.15
Free cash flow yield
-0.14-0.28-0.15-0.06-0.08
Debt to equity
0.610.650.530.40.53
Debt to assets
0.370.390.350.280.33
Net debt to EBITDA
2.272.591.740.961.46
Current ratio
1.261.041.151.471.45
Interest coverage
7.24.925.537.756.89
Income quality
0.720000
Dividend Yield
0.020.030.040.010.05
Payout ratio
0.20.170.170.110.32
Sales general and administrative to revenue
0.010.030.030.030.03
Research and developement to revenue
000.010.010.01
Intangibles to total assets
0.040.040.040.040.08
Capex to operating cash flow
-2.780000
Capex to revenue
-0.29-0.2-0.09-0.09-0.08
Capex to depreciation
-5.980000
Stock based compensation to revenue
00000
Graham number
88.06100.73113.68146.52153.35
ROIC
0.070.080.090.110.08
Return on tangible assets
0.060.060.070.10.08
Graham Net
-28.66-33.83-29.88-23.1-33.13
Working capital
2.33B518.33M1.69B4.42B5.68B
Tangible asset value
25.52B27.98B30.98B35.44B39.4B
Net current asset value
-5.04B-6.09B-4.27B-1.11B-3.09B
Invested capital
0.410.460.320.210.3
Average receivables
00000
Average payables
503.94M856.57M1.28B1.71B2.22B
Average inventory
4.91B6.19B6.69B7.26B9.46B
Days sales outstanding
00000
Days payables outstanding
24.0532.6738.9446.0747.72
Days of inventory on hand
221.49199.02178.88182.96215.34
Receivables turnover
00000
Payables turnover
15.1811.179.377.927.65
Inventory turnover
1.651.832.041.991.69
ROE
0.090.10.110.140.13
Capex per share
-11.33-10.19-5.1-5.73-6.59

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q3

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
Revenue per share
20.0819.5921.9422.1721.42
Net income per share
2.471.893.242.772.13
Operating cash flow per share
00000
Free cash flow per share
-0.39-2.47-1.53-1.56-1.12
Cash per share
1.322.621.962.792.21
Book value per share
89.1391.0194.2593.5295.65
Tangible book value per share
86.6688.3291.7391.0393.05
Share holders equity per share
89.1391.0194.2593.5295.65
Interest debt per share
27.1428.3827.6226.5326.25
Market cap
49.2B34.79B34.39B30.42B22.08B
Enterprise value
60.44B45.99B45.53B40.67B32.48B
P/E ratio
11.1610.325.946.155.81
Price to sales ratio
5.493.983.513.082.31
POCF ratio
00000
PFCF ratio
-284.37-31.57-50.39-43.84-44.06
P/B Ratio
1.240.860.820.730.52
PTB ratio
1.240.860.820.730.52
EV to sales
6.755.264.654.113.4
Enterprise value over EBITDA
32.2635.5220.7620.4520.99
EV to operating cash flow
00000
EV to free cash flow
-349.33-41.73-66.71-58.62-64.83
Earnings yield
0.020.020.040.040.04
Free cash flow yield
0-0.03-0.02-0.02-0.02
Debt to equity
0.540.530.510.570.52
Debt to assets
0.330.330.320.340.32
Net debt to EBITDA
68.655.085.166.72
Current ratio
1.431.451.591.471.58
Interest coverage
6.434.056.795.924.77
Income quality
00000
Dividend Yield
0.030000.07
Payout ratio
1.40.01001.63
Sales general and administrative to revenue
0.040.110.030.030.04
Research and developement to revenue
00.01000
Intangibles to total assets
0.080.080.080.070.07
Capex to operating cash flow
00000
Capex to revenue
-0.02-0.13-0.07-0.07-0.05
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
70.462.1982.9476.3967.72
ROIC
0.020.020.030.020.02
Return on tangible assets
0.020.010.020.020.01
Graham Net
-27.59-28.15-26.64-29.47-32.64
Working capital
5.38B5.68B7.32B6.85B7.62B
Tangible asset value
38.66B39.4B40.92B40.61B41.51B
Net current asset value
-3.46B-3.09B-1.8B-2.32B-1.36B
Invested capital
0.30.30.290.280.27
Average receivables
3.86B3.55B3.11B3.27B1.65B
Average payables
3.15B2.69B2.5B2.91B3.38B
Average inventory
10.36B10.87B11.8B12.96B13.39B
Days sales outstanding
41.5230.5129.8630.020
Days payables outstanding
53.5143.1142.6454.258.46
Days of inventory on hand
194.74194.56209.31221.95224.91
Receivables turnover
2.172.953.0130
Payables turnover
1.682.092.111.661.54
Inventory turnover
0.460.460.430.410.4
ROE
0.030.020.030.030.02
Capex per share
-0.39-2.47-1.53-1.56-1.12

BXP.L Frequently Asked Questions

What is Beximco Pharmaceuticals Limited stock symbol ?

Beximco Pharmaceuticals Limited is a BD stock and trading under the symbol BXP.L

What is Beximco Pharmaceuticals Limited stock quote today ?

Beximco Pharmaceuticals Limited stock price is $38 today.

Is Beximco Pharmaceuticals Limited stock public?

Yes, Beximco Pharmaceuticals Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap